Article

The American Journal of Managed Care Bridges the Gap Between Payers and Providers in First Annual Live Meeting

At a meeting hosted by the American Journal of Managed Care, key figures in the managed care industry discussed innovative payment models being utilized by payers and providers.

On Friday, November 16, The American Journal of Managed Care hosted its first annual live meeting, Translating Evidence-Based Research into Value-Based Decisions in Oncology. The conference, which brought together stakeholders from all sides of the managed care industry, provided an arena for healthcare professionals to discuss new, innovative payment models being utilized by both payers and providers.

Mark Fendrick, MD, Professor of Medicine and Health Management and Policy Schools of Medicine and Public Health, University of Michigan, Co-Editor-in-Chief, The American Journal of Managed Care, spoke about the importance of the meeting in his opening remarks. “It’s a pleasure to have a meeting where we can reach so many decision makers in a rapidly advancing healthcare system. It’s time to shift the focus from how much we spend to how well we spend.”

Michael Chernew, PhD, professor of health care policy, Harvard Medical School, vice chairman, MEDPAC, co-editor-in-chief, The American Journal of Managed Care, added, “What AJMC has done quite well in a meeting like this is bring people from across the spectrum together to discuss these issues. Keynote speaker Cliff Goodman, PhD, is the national expert in evidence-defined value. We have clinical experts, such as Dr. Peter Bach, who are world renowned in their knowledge of the issues surrounding oncology. And, we have a tremendous group of folks in the audience from both payers and industry to really have a thoughtful discussion about how exactly we are going to navigate the fiscal challenges the industry faces in order to allow individuals who have cancer to have access to the medications that can improve their lives.”

The conference concluded with an interactive question and answer session between presenters and attendees. “It was great to see how receptive the audience was to these presentations, and the discussion that was generated was truly an example of how progress can be made when representatives from all sides of managed care are able to come together,” said Brian Haug, president, The American Journal of Managed Care. “We are very thankful for the interest in this conference and look forward to building on our success for next year’s gathering.”

For video and written coverage of the live meeting, please visit

www.ajmc.com/conferences/TEVR2012.

About The American Journal of Managed Care

The American Journal of Managed Care is an independent, peer-reviewed publication dedicated to publishing original research in healthcare outcomes and creating a forum for scientific communication in the ever-evolving field of healthcare delivery. The journal is indexed in MEDLINE/PUBMED. AJMC is published by the Intellisphere Managed Market Group, which is owned by MJH & Associates. For more information, please contact Tobin Sharp, Group Editorial Director, The American Journal of Managed Care, at 609.716.7777 or tsharp@ajmc.com.

SOURCE: The American Journal of Managed Care

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards